Related Experiment Video
Updated: Sep 12, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Na+,-K+-ATPase Deficiency Exacerbates Cardiac Fibrosis via Promoting ERRα-Mediated Myocardial Cell Injury and
Ting Lei1, Tao Liu1,2, Yutong Liu2
1Department of Clinical Laboratory, Xi'an People's Hospital (Xi'an Fourth Hospital), 710004 Xi'an, Shaanxi, China.
Insights
Na+, K+-ATPase (NKA) α1 deficiency worsens cardiac fibrosis by increasing inflammation and cell death. Targeting the NKAα1 DR-region may offer a novel therapeutic strategy for heart disease.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Immunology
Background:
- Inflammation is a key driver of tissue fibrosis.
- Na+, K+-ATPase (NKA) α1 deficiency impairs mitochondrial function and cardiac remodeling.
- This study investigates the link between inflammation and NKAα1 deficiency in cardiac fibrosis.
Purpose of the Study:
- To elucidate the role of NKAα1 deficiency in inflammation-driven cardiac fibrosis.
- To understand the mechanisms underlying NKAα1 deficiency-induced cardiac remodeling.
- To identify potential therapeutic targets for cardiac fibrosis.
Main Methods:
- Utilized a mouse model with NKAα1 haploinsufficiency subjected to isoproterenol (ISO) challenge.
- Performed histopathology, electron microscopy, RT-qPCR, immunoblotting, and ELISA.
- Employed a cell co-culture system to study cell interactions.
Main Results:
- NKAα1 deficiency exacerbated ISO-induced cardiac fibrosis, macrophage infiltration, and inflammatory markers.
- NKAα1 deficiency accelerated cardiomyocyte death and amplified intercellular crosstalk, promoting inflammation and fibrosis.
- Estrogen-related receptor α (ERRα) mediated cardiomyocyte death and IL-18 release; a DR-region antibody reduced fibrosis.
Conclusions:
- NKAα1 deficiency exacerbates cardiac fibrosis via ERRα-dependent cardiomyocyte death and enhanced cell communication.
- NKAα1 deficiency facilitates crosstalk between cardiomyocytes, macrophages, and fibroblasts, driving fibrosis.
- NKAα1 and its DR-region are potential therapeutic targets for cardiac fibrosis.
Background:
Inflammation plays a pivotal role in the progression of tissue fibrosis. Our previous research demonstrated that Na+, K+-ATPase (NKA) α1 deficiency impairs mitochondrial function and accelerates isoproterenol (ISO)-induced cardiac remodeling. This study aims to investigate the interplay between inflammation and NKAα1 deficiency in ISO-induced cardiac fibrosis.
Methods:
Age-matched male wild-type (WT) and NKAα1+/- mice received daily subcutaneous injections of ISO (30 mg/kg body weight) over 14 consecutive days. Comprehensive histopathological evaluation was performed to assess myocardial architecture and leukocyte infiltration profiles. Mitochondrial ultrastructure was analyzed using transmission electron microscopy. The molecular techniques of real-time quantitative polymerase chain reaction (RT-qPCR), immunoblotting, and enzyme-linked immunosorbent assay (ELISA) were utilized to quantify fibrotic markers and inflammatory mediators. A cell co-culture model was established to investigate the interactions between different cell types.
Results:
NKAα1 haploinsufficiency exacerbated heart lesions and fibrosis, led to macrophage accumulation, and increased the expression of inflammatory factors in ISO-challenged hearts. Although NKAα1 deficiency did not directly activate macrophages or fibroblasts under ISO conditions, it significantly accelerated cardiomyocyte death in response to ISO insult. Paracrine crosstalk between damaged NKAα1+/- cardiomyocytes, macrophages, and fibroblasts amplified macrophage activation, inflammatory cytokine release, and fibroblast differentiation. Estrogen-related receptor α (ERRα) was identified as a key mediator of NKAα1 haploinsufficiency-induced cardiomyocyte death and interleukin-18 (IL-18) release. Furthermore, treatment with an NKAα1 897DVEDSYGQQWTYEQR911 (DR)-region antibody mitigated ISO-induced cardiac fibrosis and macrophage infiltration.
Conclusion:
This study provides evidence that NKAα1 deficiency exacerbates cardiac fibrosis by promoting ERRα-dependent cardiomyocyte death and by facilitating intercellular cross-talk between damaged NKAα1+/- cardiomyocytes, macrophages, and fibroblasts. Based on these findings, we suggest that NKAα1 may be a potential regulator of cardiac fibrosis, and that its DR-region represents a potential therapeutic target.
Related Concept Videos
Myocarditis I: Introduction
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
ATP Synthase: Mechanism
Rheumatic Heart Disease I: Introduction

